Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-072520
Filing Date
2025-05-15
Accepted
2025-05-15 15:51:33
Documents
90
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q emma-20250331.htm   iXBRL 10-Q 2758503
2 EX-10.1 emma-ex10_1.htm EX-10.1 608202
3 EX-31.1 emma-ex31_1.htm EX-31.1 12939
4 EX-31.2 emma-ex31_2.htm EX-31.2 13046
5 EX-32.1 emma-ex32_1.htm EX-32.1 12042
6 GRAPHIC img109337448_0.jpg GRAPHIC 4888
7 GRAPHIC img109337448_1.jpg GRAPHIC 34846
8 GRAPHIC img109337448_2.jpg GRAPHIC 631
9 GRAPHIC img109337448_3.jpg GRAPHIC 3530
10 GRAPHIC img109337448_4.jpg GRAPHIC 767
11 GRAPHIC img109337448_5.jpg GRAPHIC 3168
12 GRAPHIC img109337448_6.jpg GRAPHIC 2525
13 GRAPHIC img109337448_7.jpg GRAPHIC 2153
14 GRAPHIC img109337448_8.jpg GRAPHIC 2525
15 GRAPHIC img109337448_9.jpg GRAPHIC 2153
16 GRAPHIC img109337448_10.jpg GRAPHIC 2862
17 GRAPHIC img109337448_11.jpg GRAPHIC 3837
  Complete submission text file 0000950170-25-072520.txt   15636234

Data Files

Seq Description Document Type Size
18 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT emma-20250331.xsd EX-101.SCH 1673647
93 EXTRACTED XBRL INSTANCE DOCUMENT emma-20250331_htm.xml XML 3913839
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

EIN.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35527 | Film No.: 25952137
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)